by Antimicrobial susceptibility testing, also known as antibiotic sensitivity testing, is an important diagnostic application performed to determine the efficacy of specific antibiotics against a bacterial or fungal pathogen. It helps clinicians select the most appropriate antibiotic for treating infections. Antimicrobial susceptibility testing identifies microorganisms responsible for an infection and determines which antibiotics will effectively treat the infection. This provides physicians with critical information to select the most appropriate antibiotic and achieve the best treatment outcome.
The global antimicrobial susceptibility testing market is estimated to be valued at US$ 3751.4 Mn in 2023 and is expected to exhibit a CAGR of 7.9% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Dynamics:
Increasing cases of hospital-acquired infections is one of the key drivers expected to flourish the antimicrobial susceptibility testing market. According to the Centers for Disease Control and Prevention, around 1 in 31 hospital patients in the U.S. suffer from at least one hospital-acquired infection. These hospital-acquired infections increase the burden on healthcare systems resulting in prolonged hospital stays and increased medical costs. Antimicrobial susceptibility testing helps identify the causative pathogen and select the most effective antibiotic for treatment, thereby improving patient outcomes and reducing healthcare costs associated with prolonged antibiotic therapy and repeat hospitalization. Additionally, rising antibiotic resistance is propelling the need for timely and accurate antimicrobial susceptibility testing to optimize antibiotic usage and curb the spread of drug-resistant organisms. However, the complexity of antimicrobial susceptibility testing procedures and workflow bottlenecks pose challenges to widespread adoption.
Segment Analysis
The global antimicrobial susceptibility testing market is dominanted by the products segment which holds more than 40% share of the total market. Within the products segment, automated laboratory instruments sub-segment dominates due to greater efficiency and reliability offered by these instruments compared to manual instruments. The automated instruments allow conducting large number of tests rapidly and reduce manual errors.
PEST Analysis
Political: Governments across the globe are focusing on controling antimicrobial resistance by regularly monitoring antimicrobial resistance pattern in healthcare settings which is boosting the market.
Economic: Rising healthcare expenditure along with growing incidence of infectious diseases is fueling the demand.
Social: Increasing public awareness about AMR and need for prompt diagnosis and treatment of infectious diseases is driving the market growth.
Technological: Continous innovation in automated susceptibility testing systems with software for improved analysis is supporting the growth.
Key Takeaways
Global Antimicrobial Susceptibility Testing Market Size is expected to witness high growth at a CAGR of 7.9% during the forecast period of 2023 to 2030. The global antimicrobial susceptibility testing market is estimated to be valued at US$ 3751.4 Mn in 2023 and is expected to exhibit a CAGR of 7.9% over the forecast period 2023 to 2030.
Regional analysis:
North America dominates the market currently due to presence of most number of market players and advanced healthcare infrastructure in countries like US and Canada. The region is expected to continue dominating during the forecast period.
Key players: Thermo Fisher Scientific Inc., Cytiva, and Sartorius AG are the key players operating in the antimicrobial susceptibility testing market. Key players: Thermo Fisher Scientific Inc. is the global leader in susceptibility testing products with wide range of automated instruments like Phoenix, MicroScan, and Vitek. Cytiva offers manual and automated testing platforms like Etest and Vitek 2. Sartorius AG provides MICroLUX, MICROSTATION and NEWSensitest instruments.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc.
